PBH
MaterialsPrestige Consumer Healthcare Inc
Live · NYSE · May 9, Close
What's Moving PBH Today?
No stock-specific AI insight has been generated for PBH yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Trading
PBH News
21 articles- Rockwell Medical (RMTI) Reports Q1 Loss, Misses Revenue EstimatesYahoo Finance·May 7, 2026
- LeMaitre Vascular (LMAT) Tops Q1 Earnings EstimatesYahoo Finance·May 5, 2026
- Prestige Consumer Healthcare to Release Fiscal 2026 Fourth Quarter and Year-End Earnings ResultsYahoo Finance·Apr 30, 2026
- National Advertising Division Finds Certain Eosera Ear Wax MD Claims Supported; Recommends Others Be Modified or DiscontinuedGlobeNewswire Inc.·Apr 23, 2026
- Has Prestige Consumer Healthcare (PBH) Fallen Too Far After Its 32% One-Year Share Price DropYahoo Finance·Apr 6, 2026
- Prestige Consumer Healthcare (PBH) Is Down 10.3% After Rising FTC Scrutiny and Bearish Signals - What's ChangedYahoo Finance·Apr 6, 2026
- A Look At Premium Brands Holdings (TSX:PBH) Valuation After Recent Share Price WeaknessYahoo Finance·Apr 6, 2026
- Prestige Consumer Healthcare’s (PBH) Free Cash Flow to Enterprise Value Stood at 6.5%Yahoo Finance·Mar 25, 2026
- Sector Update: Health Care Stocks Retreat Late AfternoonYahoo Finance·Mar 20, 2026
- Sector Update: Health Care Stocks Retreat Friday AfternoonYahoo Finance·Mar 20, 2026
- Prestige Consumer Healthcare to Acquire Consumer Health, Wellness Brands Portfolio in $1.05 Billion DealYahoo Finance·Mar 20, 2026
- Foundation Consumer Healthcare Sells Portion of Consumer Health BusinessYahoo Finance·Mar 20, 2026
- Prestige Consumer Healthcare Announces Agreement to Acquire Breathe Right®, the Leader in Nasal StripsYahoo Finance·Mar 20, 2026
- Premium Brands Q4 Earnings Call HighlightsMarketbeat·Mar 19, 2026
- PREMIUM BRANDS HOLDINGS CORPORATION REPORTS RECORD FOURTH QUARTER SALES, ADJUSTED EBITDA, AND ADJUSTED EPS, ANNOUNCES THE SALE OF ITS INTEREST IN SHAW BAKERS, DECLARES FIRST QUARTER DIVIDEND AND APPOINTS NEW DIRECTOR TO ITS BOARDYahoo Finance·Mar 19, 2026
- Prestige Consumer Healthcare Selects Horizon Media as Agency of Record to Drive Market GrowthYahoo Finance·Mar 16, 2026
- Clear Eyes Supply Disruption Weighs on Prestige Consumer Healthcare Inc. (PBH)’s Quarterly RevenueYahoo Finance·Feb 18, 2026
- PBH's Q3 Earnings Miss Estimates, Revenues Surpass, Stock UpYahoo Finance·Feb 12, 2026
- Prestige Consumer Healthcare (PBH) Valuation Check After Clear Eyes Supply Headwinds And Pillar5 AcquisitionYahoo Finance·Feb 7, 2026
- Prestige Consumer Healthcare Q3 Earnings Call HighlightsMarketbeat·Feb 7, 2026
- Haemonetics Q3 Earnings & Revenues Beat, Margins Up, Stock SlipsYahoo Finance·Feb 6, 2026
All 21 articles loaded
Price Data
Fundamentals
Trading
About Prestige Consumer Healthcare Inc
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.